FDA approves Achaogen’s Zemdri to treat adults with cUTI

This article was originally published here

Achaogen has secured approval from the US Food and Drug Administration (FDA) for its Zemdri (plazomicin) to treat adults with complicated urinary tract infections (cUTI).

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply